James M. Ahlers
Chief Financial Officer · Cue Biopharma, Inc.
Individual
- 2026
- Aug 3, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies James M. Ahlers files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Shao-Lee Lin - $2.61M in CUE purchases and sales in the last 12 months
- Sumita Ray - $266K in CUE purchases and sales in the last 12 months
- Michael Vincent Meluzio - $169K in CUE purchases and sales in the last 12 months
- Pasha Sarraf - $100K in CUE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James M. Ahlers?
James M. Ahlers is a corporate insider, tracked as Chief Financial Officer of Cue Biopharma, Inc. (CUE). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has James M. Ahlers submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
